Pfizer Just Locked Next Growth Path: What Investors Should Know
Pfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
We review which stablecoins fall under regulatory scrutiny, the regimes that apply, and practical implications for users and providers alike.
19,420 articlesPfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
Interpol links a crypto wallet tied 20-year-old to $122.5 million moved in 10 months, prompting a worldwide push agai...
The 2026 Hedge Fund Alternative Manager Forum brought together leaders to share how AI, data, and differentiated stra...
GhostSwap launches a no-onboarding swap experience that lets users exchange 1,600+ tokens in minutes, without email, ...
Investors eye the Fennec Q1 2026 call to gauge milestones, cash runway, and potential catalysts. This guide breaks do...
Nvidia remains the AI chip leader, but Broadcom and Marvell are gaining ground as hyperscalers push for lower costs t...
When top executives trim stakes, investors take note. This article breaks down the meaning behind such moves, with a ...
Alphabet reports higher capital investment as it bets on AI and cloud, challenging the resilience of its trillion-dol...
Iren has closed a $3 billion convertible notes sale at a 1% coupon, due 2033, to bankroll its AI cloud infrastructure...
A sudden political pivot put South Carolina in the spotlight as former President Trump floated Darline Graham Nordone...
As May 2026 unfolds, smart investors are looking for durable growth in healthcare. Here are three standout names, why...
Hyperliquid’s hip-3 markets surge has pushed HIP-3’s share of perpetual futures volume to roughly half, signaling a d...